Abstract
The continuing emergence of infections due to multidrug resistant bacteria is a serious public health problem. Klebsiella pneumoniae, which commonly acquires resistance encoded on mobile genetic elements, including ones that encode carbapenemases, is a prime example. K. pneumoniae carrying such genetic material, including both blaKPCand genes encoding metallo-β-lactamases, have spread globally. Many carbapenemase-producing K. pneumoniae are resistant to multiple antibiotic classes beyond β-lactams, including tetracyclines, aminoglycosides, and fluoroquinolones. The optimal treatment, if any, for infections due to these organisms is unclear but, paradoxically, appears to often require the inclusion of an optimally administered carbapenem.
Cite
CITATION STYLE
Robilotti, E., & Deresinski, S. (2014). Carbapenemase-producing Klebsiella pneumoniae. F1000Prime Reports, 6. https://doi.org/10.12703/P6-80
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.